J. Adamson, J. Lally, F. Gaughran, A. Krivoy, L. Allen et al., Correlates of vitamin D in psychotic disorders: A comprehensive systematic review, Psychiatry Res, vol.249, pp.78-85, 2017.

K. S. Akinlade, O. A. Olaniyan, V. O. Lasebikan, and S. K. Rahamon, Vitamin D Levels in Different Severity Groups of Schizophrenia. Front, Psychiatry, vol.8, p.105, 2017.

K. G. Alberti, P. Zimmet, and J. Shaw, Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation, Diabet. Med, vol.23, pp.469-480, 2006.

M. Andrianarisoa, L. Boyer, O. Godin, L. Brunel, E. Bulzacka et al., Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort, Schizophr. Res, vol.185, pp.173-181, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01792072

K. Archontogeorgis, E. Nena, N. Papanas, M. Rizzo, A. Voulgaris et al., Metabolic Syndrome and Vitamin D Levels in Patients with Obstructive Sleep Apnea Syndrome, Metab. Syndr. Relat. Disord, vol.16, pp.190-196, 2018.

A. D. Baddeley, H. Emslie, and I. Nimmo-smith, Doors and people: A test of visual and verbal recall and recognition, 1994.

S. M. Barbalho, R. J. Tofano, A. L. De-campos, A. S. Rodrigues, K. Quesada et al., Association between vitamin D status and metabolic syndrome risk factors, Diabetes Metab. Syndr, 2018.

M. Belvederi-murri, M. Respino, M. Masotti, M. Innamorati, V. Mondelli et al., Vitamin D and psychosis: mini meta-analysis, Schizophr. Res, vol.150, pp.235-239, 2013.

R. Belzeaux, L. Boyer, E. C. Ibrahim, F. Féron, M. Leboyer et al., Mood disorders are associated with a more severe hypovitaminosis D than schizophrenia, Psychiatry Res, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02282160

R. Bender and S. Lange, Adjusting for multiple testing-when and how?, J. Clin. Epidemiol, vol.54, pp.343-349, 2001.

R. Boerman, D. Cohen, P. F. Schulte, and A. Nugter, Prevalence of Vitamin D Deficiency in Adult Outpatients With Bipolar Disorder or Schizophrenia, J. Clin. Psychopharmacol, vol.36, pp.588-592, 2016.

J. P. Bogers, T. Bostoen, and T. G. Broekman, Low levels of vitamin D poorly responsive to daylight exposure in patients with therapy-resistant schizophrenia, Nord. J. Psychiatry, vol.70, pp.262-266, 2016.

K. Cieslak, J. Feingold, D. Antonius, J. Walsh-messinger, R. Dracxler et al., Low vitamin D levels predict clinical features of schizophrenia, Schizophr. Res, vol.159, pp.543-545, 2014.

C. Custodero, R. T. Mankowski, S. A. Lee, Z. Chen, S. Wu et al., Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis, Ageing Res. Rev, vol.46, pp.42-59, 2018.

D. C. Delis, J. H. Kramer, E. Kaplan, and B. A. Ober, California Verbal Learning Test, The Psychological Corporation. Harcourt Assessment Company, 2000.

D. Bulut, S. Bulut, S. Görkem-atalan, D. Berkol, T. Gürçay et al., The Relationship between Symptom Severity and Low Vitamin D Levels in Patients with Schizophrenia, PloS One, vol.11, 2016.

J. Firth, R. Carney, B. Stubbs, S. B. Teasdale, D. Vancampfort et al., Nutritional Deficiencies and Clinical Correlates in First-Episode Psychosis: A Systematic Review and Meta-analysis, 2017.

G. Fond, L. Boyer, F. Berna, O. Godin, E. Bulzacka et al., Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort, Br. J. Psychiatry J. Ment. Sci, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01814845

G. Fond, Hypovitaminosis D is associated with negative symptoms, suicide risk, agoraphobia, impaired functional remission, and antidepressant consumption in schizophrenia, Eur. Arch. Psychiatry Clin. Neurosci, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02473642

G. Fond, S. Guillaume, S. Artero, P. Bernard, G. Ninot et al., Self-reported major depressive symptoms at baseline impact abstinence prognosis in smoking cessation program. A one-year prospective study, J. Affect. Disord, vol.149, pp.418-421, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02466973

G. Fond, S. Guillaume, I. Jaussent, S. Beziat, A. Macgregor et al., Prevalence and Smoking Behavior Characteristics of Nonselected Smokers With Childhood and/or Adult Self-Reported ADHD Symptoms in a Smoking-Cessation Program: A Cross-Sectional Study, J. Atten. Disord, 2013.

S. G. Garbossa and F. Folli, Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism, Rev. Endocr. Metab. Disord, vol.18, pp.243-258, 2017.

O. Godefroy, Fonctions exécutives et pathologies neurologiques et psychiatriques: évaluation en pratique clinique, 2008.

K. A. Graham, R. S. Keefe, J. A. Lieberman, A. S. Calikoglu, K. M. Lansing et al., Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia, Early Interv. Psychiatry, vol.9, pp.397-405, 2015.

P. D. Harvey, Mood Symptoms, Cognition, and Everyday Functioning, Innov. Clin. Neurosci, vol.8, pp.14-18, 2011.

D. Itzhaky, D. Amital, K. Gorden, A. Bogomolni, Y. Arnson et al., Low serum vitamin D concentrations in patients with schizophrenia, Isr. Med. Assoc. J. IMAJ, vol.14, pp.88-92, 2012.

S. Ju, Y. Lee, and S. Jeong, Serum 25-hydroxyvitamin D levels and the risk of depression: a systematic review and meta-analysis, J. Nutr. Health Aging, vol.17, pp.447-455, 2013.

D. Kim, The Role of Vitamin D in Thyroid Diseases, Int. J. Mol. Sci, vol.18, 2017.

A. Krivoy, R. Onn, Y. Vilner, E. Hochman, S. Weizman et al., Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial. EBioMedicine, vol.26, pp.138-145, 2017.

P. P. Lerner, L. Sharony, and C. Miodownik, Association between mental disorders, cognitive disturbances and vitamin D serum level: Current state, Clin. Nutr. ESPEN, vol.23, pp.89-102, 2018.

A. M. Leventhal, C. Witt, and M. Zimmerman, Associations between depression subtypes and substance use disorders, Psychiatry Res, vol.161, pp.43-50, 2008.

A. Mackinnon and R. Mulligan, , 2005.

H. E. Nelson and A. O'connell, Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test, Cortex J. Devoted Study Nerv. Syst. Behav, vol.14, pp.234-244, 1978.

M. Nerhus, A. O. Berg, L. R. Kvitland, I. Dieset, S. Hope et al., Low vitamin D is associated with negative and depressive symptoms in psychotic disorders, Schizophr. Res, vol.178, pp.44-49, 2016.

K. H. Nuechterlein, M. F. Green, R. S. Kern, L. E. Baade, D. M. Barch et al., The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity, Am. J. Psychiatry, vol.165, pp.203-213, 2008.

J. Poitrenaud, B. Deweer, M. Kalafat, and M. Van-der-linden, Adaptation en langue française du California Verbal Learning Test, Paris Éditions Cent. Psychol. Appliquée, 2007.

R. M. Reitan, Validity of the Trail Making Test as an indicator of organic brain damage, Percept. Mot. Skills, vol.8, pp.271-276, 1958.

P. Roux, D. Misdrahi, D. Capdevielle, B. Aouizerate, F. Berna et al., Mediation Analyses of Insight, Quality of Life, Depression, and Suicidality: Results From the FACE-SZ Cohort, J. Clin. Psychiatry, vol.79, 2018.

J. J. Ryan and L. C. Ward, Validity, reliability, and standard errors of measurement for two seven-subtest short forms of the Wechsler Adult Intelligence Scale-III, Psychol. Assess, vol.11, p.207, 1999.

C. Schefft, L. L. Kilarski, T. Bschor, and S. Köhler, Efficacy of adding nutritional supplements in unipolar depression: A systematic review and meta-analysis, Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol, vol.27, pp.1090-1109, 2017.

F. Schürhoff, G. Fond, F. Berna, E. Bulzacka, J. Vilain et al., FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) collaborators, 2015. A National network of schizophrenia expert centres: An innovative tool to bridge the research-practice gap, Eur. Psychiatry J. Assoc. Eur. Psychiatr

V. Shivakumar, S. V. Kalmady, A. C. Amaresha, D. Jose, J. C. Narayanaswamy et al., Serum vitamin D and hippocampal gray matter volume in schizophrenia, Psychiatry Res, vol.233, pp.175-179, 2015.

J. Souberbielle, C. Massart, S. Brailly-tabard, E. Cavalier, and P. Chanson, Prevalence and determinants of vitamin D deficiency in healthy French adults: the VARIETE study, Endocrine, vol.53, pp.543-550, 2016.

V. S. Tardelli, M. P. Lago, . Do, D. X. Silveira, . Da et al., Vitamin D and alcohol: A review of the current literature, Psychiatry Res, vol.248, pp.83-86, 2017.

, Situation nutritionnelle en France en 2006 selon les indicateurs d'objectif et les repères du Programme national nutrition santé (PNNS), Conservatoire national des arts et métiers, vol.13, p.46, 2006.

R. S. Wallwork, R. Fortgang, R. Hashimoto, D. R. Weinberger, and D. Dickinson, Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia, Schizophr. Res, vol.137, pp.246-250, 2012.

S. Wang, Y. Wu, Z. Zuo, Y. Zhao, and K. Wang, The effect of vitamin D supplementation on thyroid autoantibody levels in the treatment of autoimmune thyroiditis: a systematic review and a meta-analysis, Endocrine, vol.59, pp.499-505, 2018.

D. Wechsler, Echelle d'intelligence de Wechsler pour adultes: WAIS-III, 2008.

T. Yoo, W. Choi, J. Hong, J. Lee, J. Kim et al., Association Between Vitamin D Insufficiency and Metabolic Syndrome in Patients With Psychotic Disorders, Psychiatry Investig, vol.15, pp.396-401, 2018.

R. N. Yüksel, N. Altunsoy, B. Tikir, M. Cingi-külük, K. Unal et al., Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add, 2014.

, Ther. Adv. Psychopharmacol, vol.4, pp.268-275

D. Zhu, Y. Liu, A. Zhang, Z. Chu, Q. Wu et al., High levels of vitamin D in relation to reduced risk of schizophrenia with elevated C-reactive protein, Psychiatry Res, vol.228, pp.565-570, 2015.

W. Zhu and D. P. Heil, Associations of vitamin D status with markers of metabolic health: A community-based study in, Diabetes Metab. Syndr, 2018.